In an adult mechanically ventilated patient with stable hemodynamics, adequate oxygenation (arterial oxygen tension ≥150 mm Hg on fraction of inspired oxygen ≤0.5, positive end‑expiratory pressure ≤5 cm H₂O), resolved cause of respiratory failure, alertness, and low sedation, how should a spontaneous breathing trial be performed and which clinical and ventilatory parameters should be monitored to determine success?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Perform a Spontaneous Breathing Trial

Conduct the initial spontaneous breathing trial using pressure support ventilation of 5–8 cm H₂O with PEEP 5 cm H₂O for 30 minutes in standard-risk patients, monitoring for signs of respiratory distress, hemodynamic instability, or oxygen desaturation. 1, 2

Pre-SBT Readiness Screening

Before initiating any SBT, confirm the patient meets all of the following criteria daily:

  • Patient is arousable and able to follow simple commands (open eyes, maintain eye contact, squeeze hand) 2
  • Hemodynamic stability without significant vasopressor requirements and no active myocardial ischemia 1, 2
  • Adequate oxygenation: PaO₂ ≥150 mm Hg on FiO₂ ≤0.5 and PEEP ≤5 cm H₂O 3, 1
  • Resolution or improvement of the primary cause of respiratory failure 1, 2
  • Minimal sedation targeting a level where the patient can interact 2

SBT Technique and Duration

Standard-Risk Patients

  • Use pressure support 5–8 cm H₂O with PEEP 5 cm H₂O rather than T-piece or CPAP alone 1, 2
  • Duration: 30 minutes, as most SBT failures occur within this timeframe 1, 2
  • This approach achieves 84.6% SBT success versus 76.7% with T-piece 1, 2

High-Risk Patients

  • Extend SBT duration to 60–120 minutes for more accurate assessment 1, 2
  • Consider using T-piece or CPAP without pressure support to better assess true extubation readiness 1, 2
  • High-risk factors include: COPD or heart failure, prolonged ventilation >14 days, previous failed extubation, ineffective cough, impaired bulbar function, or age >65 with multiple comorbidities 1, 2, 4

Parameters to Monitor During SBT

Immediate Failure Criteria (Terminate SBT and Resume Ventilation)

Respiratory parameters:

  • Oxygen saturation <90% 2
  • Respiratory rate increase with accessory muscle use or paradoxical breathing 1
  • Subjective dyspnea or increased work of breathing 1

Hemodynamic parameters:

  • Heart rate >140 beats/min or sustained increase >20% from baseline 2
  • Systolic blood pressure >180 mm Hg or <90 mm Hg 2

Neurologic parameters:

  • Increased anxiety, agitation, or altered mental status 1, 2
  • Diaphoresis 1, 2

Post-SBT Assessment Before Extubation

Passing the SBT alone is insufficient—approximately 10% of patients who pass still fail extubation within 48 hours. 1, 4 Therefore, assess the following additional factors:

Airway Competence

  • Cough strength: Patients with weak cough (grade 0–2 on 0–5 scale) are 4 times more likely to fail extubation 5
  • Secretion burden: Moderate-to-abundant secretions increase extubation failure risk 8.7-fold 5
  • White card test: Ask patient to cough onto a card held 1–2 cm from the endotracheal tube; if secretions are propelled onto the card, this predicts successful extubation 5
  • The combination of weak cough AND abundant secretions increases failure risk 32-fold 5

Upper Airway Patency

  • Perform cuff leak test in patients at high risk for post-extubation stridor (intubated >7 days, traumatic intubation, prolonged high cuff pressures) 2
  • If cuff leak test fails, administer systemic corticosteroids at least 4 hours before extubation 2

Bulbar Function

  • Assess swallowing ability and gag reflex to ensure airway protection 1, 4

Post-Extubation Management

High-Risk Patients Who Pass SBT

Extubate directly to preventive noninvasive ventilation (NIV) applied immediately after tube removal rather than standard oxygen therapy 2, 4

This strategy reduces:

  • Reintubation by 39% (RR 0.61,95% CI 0.48–0.79) 2
  • Mortality by 46% (RR 0.54,95% CI 0.41–0.70) 2
  • ICU length of stay 2

Standard-Risk Patients

Extubate to high-flow nasal oxygen (40–60 L/min) rather than conventional oxygen 2

Critical Pitfalls to Avoid

  • Do not increase FiO₂ during the SBT, as this masks the patient's true oxygenation capability 6
  • Do not rely solely on rapid shallow breathing index (RSBI) to determine SBT readiness; it is not necessary and adds no predictive value 6
  • Do not use T-piece trials in patients with cardiovascular instability, as they impose excessive respiratory load and hemodynamic stress 1
  • Do not delay extubation in high-risk patients who pass an SBT; apply preventive NIV immediately 2
  • Do not repeat SBT on the same day after failure; identify and address reversible causes first, as repeated attempts lead to respiratory muscle fatigue 1
  • Do not use gradual weaning modes (SIMV or progressive pressure support reduction) as the primary liberation strategy; daily SBTs are superior 2

Implementation Protocol

The Surviving Sepsis Campaign strongly recommends using a protocolized weaning approach that includes daily screening and standardized SBT protocols, which reduces mechanical ventilation duration by approximately 25 hours and ICU stay by 1 day 3, 2

References

Guideline

T-Piece Spontaneous Breathing Trial Duration and Criteria for Extubation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Spontaneous Breathing Trial Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Spontaneous Breathing Trials in Mechanical Ventilation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the indications for a Spontaneous Breathing Trial (SBT) in a patient on mechanical ventilation?
What are the guidelines for conducting a spontaneous breathing trial (SBT) in a mechanically ventilated patient?
What is the protocol for conducting a daily spontaneous breathing trial (SBT) in a mechanically ventilated patient?
What is the protocol for a Spontaneous Breathing Trial (SBT) in patients undergoing mechanical ventilation?
What are Sputum Aspiration Tests (SATs) and Spontaneous Breathing Trials (SBTs) in the context of a post-hip replacement surgery patient?
What is the most appropriate and safe medication adjustment for a 71-year-old woman with severe dementia, exit seeking, severe delusions and agitation, who is currently taking sertraline 100 mg daily, melatonin 10 mg twice daily, and trazodone 25 mg at bedtime?
Can a patient already taking carbamazepine safely start Depakote (valproic acid)?
What does an elevated parathyroid hormone (PTH) of 134 pg/mL with normal serum calcium (9.3 mg/dL) and sufficient 25‑hydroxy‑vitamin D (43.4 ng/mL) indicate?
What topical corticosteroid otic solution should be prescribed for an adult with eczema of the external auditory canal?
Is zolpidem 10 mg immediate‑release equivalent to zolpidem 6.25 mg controlled‑release?
Is high‑dose chemotherapy (HDCT) with autologous stem‑cell transplantation (ASCT) curative for a fit patient under 65 years old with relapsed classical Hodgkin lymphoma who has achieved at least a partial remission after salvage chemotherapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.